Fortrea Sponsors SCRS Collaborate Forward To Revolutionise Clinical Research Practices
KUALA LUMPUR, Feb 21 (Bernama) -- Fortrea, a global contract research organisation (CRO), has announced its sponsorship of the Society for Clinical Research Sites (SCRS) Collaborate Forward working group.
This initiative will bring together 16 major Global Impact Partner organisations to explore and develop best practices to reduce administrative burdens across the clinical research ecosystem.
Fortrea senior vice president (SVP) of Global Project Delivery, Mike Clay emphasised the importance of collaboration in navigating the growing complexity of clinical trials.
“This initiative will develop tangible solutions that clinical study sponsors, CROs, vendors, sites and patient advocacy groups can rally behind,” he said in a statement.
Meanwhile, SCRS SVP, Strategy and Global Business Partnerships, Sean Soth highlighted the collaborative nature of the initiative, which will focus on sharing successful partnerships that impact clinical research across people, processes, and technology.
“This partnership underscores the value of cross-industry collaboration and the collective effort needed to drive meaningful progress in creating a more connected and efficient clinical trial ecosystem,” added Soth.
The working group aims to promote transparency and collaboration to improve clinical site efficiency, with the goal of making clinical trials more sustainable and accessible—ultimately leading to a smoother experience for patients.
Fortrea’s sponsorship marks a significant investment in fostering industry-wide innovation and reflects the company’s dedication to placing sites at the forefront of clinical trial planning.
Collaborate Forward will initially focus on study startup, showcasing the advantages of collaboration through compelling stories, case studies and data-driven insights.
Throughout 2025, Fortrea and SCRS will share updates from the group at SCRS Site Solutions Summits, with contributions from sponsors and CROs aimed at creating a more effective and connected clinical research environment.
-- BERNAMA